• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

仅在卵泡晚期接受低剂量重组人绒毛膜促性腺激素α（艾泽）治疗的体外受精患者中促黄体生成素活性的疗效。

Efficacy of luteinizing hormone activity in patients undergoing in vitro fertilization and treated only with low-dose recombinant choriogonadotropin alfa (Ovidrel) in the late follicular phase.

作者信息

Kenigsberg Daniel, Madankumar Rajeevi, Moodie Glenn, Brenner Steven H

机构信息

Department of Obstetrics, Gynecology and Reproductive Medicine, SUNY, Stony Brook School of Medicine, Stony Brook, New York, USA.

出版信息

Fertil Steril. 2006 Oct;86(4):1023-5. doi: 10.1016/j.fertnstert.2006.03.038. Epub 2006 Sep 1.

DOI:10.1016/j.fertnstert.2006.03.038
PMID:16949587
Abstract

Ten good prognosis patients underwent IVF with a new ovarian stimulation protocol using only 8 microg of recombinant choriogonadotropin and a GnRH antagonist starting at a 14-mm lead follicle. Six of the 10 subjects delivered and all had supernumerary embryos for cryopreservation.

摘要

10例预后良好的患者采用一种新的卵巢刺激方案进行体外受精，该方案仅使用8微克重组人绒毛膜促性腺激素，并在主导卵泡直径达14毫米时开始使用促性腺激素释放激素拮抗剂。10名受试者中有6名分娩，且所有患者都有多余的胚胎用于冷冻保存。

相似文献

1
Efficacy of luteinizing hormone activity in patients undergoing in vitro fertilization and treated only with low-dose recombinant choriogonadotropin alfa (Ovidrel) in the late follicular phase.仅在卵泡晚期接受低剂量重组人绒毛膜促性腺激素α（艾泽）治疗的体外受精患者中促黄体生成素活性的疗效。
Fertil Steril. 2006 Oct;86(4):1023-5. doi: 10.1016/j.fertnstert.2006.03.038. Epub 2006 Sep 1.
2
Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial.卵泡晚期每日低剂量人绒毛膜促性腺激素刺激卵巢用于体外受精：一项前瞻性随机试验。
Fertil Steril. 2006 Oct;86(4):830-8. doi: 10.1016/j.fertnstert.2006.02.110. Epub 2006 Sep 11.
3
Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.在微刺激周期中，于卵泡中期使用重组促卵泡激素联合重组促黄体生成素或低剂量重组人绒毛膜促性腺激素进行促排卵对卵巢低反应者的临床效果。
Fertil Steril. 2007 Sep;88(3):665-9. doi: 10.1016/j.fertnstert.2006.11.150. Epub 2007 Feb 12.
4
Effect of midfollicular luteinizing hormone levels on ovarian response and pregnancy outcome in patients undergoing in vitro fertilization in a short-term protocol.短期方案体外受精患者卵泡中期促黄体生成素水平对卵巢反应及妊娠结局的影响
Fertil Steril. 2005 Apr;83(4):1043-6. doi: 10.1016/j.fertnstert.2004.12.015.
5
[Use of recombinant human luteinizing hormone for ovulation stimulation in in vitro fertilization-embryo transfer].重组人促黄体生成素在体外受精-胚胎移植中用于促排卵的应用
Zhonghua Fu Chan Ke Za Zhi. 2010 Jun;45(6):420-3.
6
Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.促性腺激素释放激素激动剂/重组促卵泡生成素与促性腺激素释放激素拮抗剂/重组促卵泡生成素对体外受精期间卵泡液中黏附分子水平的影响
Fertil Steril. 2007 Jan;87(1):39-47. doi: 10.1016/j.fertnstert.2006.05.078. Epub 2006 Nov 2.
7
Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.反应不良女性的卵巢反应及妊娠结局：一项关于补充黄体生成素对体外受精周期影响的随机对照试验
Fertil Steril. 2008 Mar;89(3):546-53. doi: 10.1016/j.fertnstert.2007.03.088. Epub 2007 May 29.
8
Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues?在接受促性腺激素释放激素类似物控制性卵巢刺激的患者中，第3天黄体生成素水平能否预测体外受精的成功率？
Fertil Steril. 2008 Oct;90(4):1297-300. doi: 10.1016/j.fertnstert.2007.10.058. Epub 2008 Feb 4.
9
Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.对于既往体外受精结局不佳的患者，在促性腺激素刺激前，黄体期雌二醇贴片与促性腺激素释放激素拮抗剂抑制方案对比微剂量促性腺激素释放激素激动剂方案的研究
Fertil Steril. 2009 Jul;92(1):226-30. doi: 10.1016/j.fertnstert.2008.04.024. Epub 2008 Aug 3.
10
Substituting human chorionic gonadotropin by gonadotropin-releasing hormone agonist to trigger final follicular maturation, during controlled ovarian hyperstimulation, results in less systemic inflammation.在控制性卵巢过度刺激过程中，用促性腺激素释放激素激动剂替代人绒毛膜促性腺激素来触发最终卵泡成熟，可减少全身炎症反应。
Gynecol Endocrinol. 2006 Aug;22(8):437-40. doi: 10.1080/09513590600881339.

引用本文的文献

1
Optimisation of the follicular phase in IVF/ICSI.体外受精/卵胞浆内单精子注射中卵泡期的优化
Facts Views Vis Obgyn. 2012;4(3):203-12.